WCN24-2405 RENAL REPLACEMENT THERAPY IN SEROTONIN SYNDROME AFTER CONCURRENT USE OF LINEZOLID, VENLAFAXINE AND TACROLIMUS
Saved in:
| Main Authors: | Angie Lobo, Christian Haudenschild, Peter Thorne, Nattawat Klomjit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924001608 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linezolid and serotonin syndrome
by: Haytham A. Wali
Published: (2025-02-01) -
WCN24-2548 SHORT-TERM OUTCOMES WITH NO TAPERING TACROLIMUS TO BELATACEPT CONVERSION IN RENAL TRANSPLANT RECIPIENTS (RTRs)
by: Adela Mattiazzi, et al.
Published: (2024-04-01) -
Determination of Tramadol, Tapentadol, Venlafaxine, and Ketamine in Non-Biological Matrices
by: Diksha Thakur, et al.
Published: (2025-06-01) -
WCN24-1998 SURVIVAL ON CHRONIC DIALYSIS ASSOCIATED WITH THE TYPE OF RENAL REPLACEMENT TREATMENT OF INITIATION IN ARGENTINA
by: Guillermo Rosa-Diez, et al.
Published: (2024-04-01) -
WCN24-2126 KIDNEY REPLACEMENT THERAPY IN LATIN AMERICA, 2021 DATA
by: Guillermo Rosa-Diez, et al.
Published: (2024-04-01)